489 related articles for article (PubMed ID: 1375700)
41. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
[TBL] [Abstract][Full Text] [Related]
42. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
43. Functional consequences of cAMP accumulation in human natural killer cells. Implications for IL-2 and IL-4 signal transduction.
Vitté-Mony I; Stancou R; Bertoglio JH
J Immunol; 1990 Dec; 145(12):4272-8. PubMed ID: 2175326
[TBL] [Abstract][Full Text] [Related]
44. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Robertson MJ; Cochran KJ; Cameron C; Le JM; Tantravahi R; Ritz J
Exp Hematol; 1996 Feb; 24(3):406-15. PubMed ID: 8599969
[TBL] [Abstract][Full Text] [Related]
45. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Izquierdo M; López-Botet M
J Immunol; 1991 Jul; 147(2):714-21. PubMed ID: 1830071
[TBL] [Abstract][Full Text] [Related]
46. CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of the CD16+CD8+CD3- subset.
Mansour I; Doinel C; Rouger P
AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1451-7. PubMed ID: 2150319
[TBL] [Abstract][Full Text] [Related]
47. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.
Gong JH; Maki G; Klingemann HG
Leukemia; 1994 Apr; 8(4):652-8. PubMed ID: 8152260
[TBL] [Abstract][Full Text] [Related]
48. Long-term cultures of human peripheral blood lymphocytes with recombinant human interleukin-2 generate a population of virtually pure CD3+ CD16- CD56- large granular lymphocyte LAK cells.
Roussel E; Gerrard JM; Greenberg AH
Clin Exp Immunol; 1990 Nov; 82(2):416-21. PubMed ID: 1700746
[TBL] [Abstract][Full Text] [Related]
49. Human fetal liver-derived CD7+CD2lowCD3-CD56- clones that express CD3 gamma, delta, and epsilon and proliferate in response to interleukin-2 (IL-2), IL-3, IL-4, or IL-7: implications for the relationship between T and natural killer cells.
Hori T; Phillips JH; Duncan B; Lanier LL; Spits H
Blood; 1992 Sep; 80(5):1270-8. PubMed ID: 1381242
[TBL] [Abstract][Full Text] [Related]
50. Monocyte-induced down-modulation of CD16 and CD56 antigens on human natural killer cells and its regulation by histamine H2-receptors.
Hellstrand K; Kjellson B; Hermodsson S
Cell Immunol; 1991 Nov; 138(1):44-54. PubMed ID: 1717164
[TBL] [Abstract][Full Text] [Related]
51. Synergistic activation of human natural killer cell cytotoxicity by histamine and interleukin-2.
Hellstrand K; Hermodsson S
Int Arch Allergy Appl Immunol; 1990; 92(4):379-89. PubMed ID: 2150668
[TBL] [Abstract][Full Text] [Related]
52. In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors.
Mingari MC; Poggi A; Biassoni R; Bellomo R; Ciccone E; Pella N; Morelli L; Verdiani S; Moretta A; Moretta L
J Exp Med; 1991 Jul; 174(1):21-6. PubMed ID: 1711562
[TBL] [Abstract][Full Text] [Related]
53. Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.
Zupo S; Azzoni L; Massara R; D'Amato A; Perussia B; Ferrarini M
J Clin Immunol; 1993 May; 13(3):228-36. PubMed ID: 7686565
[TBL] [Abstract][Full Text] [Related]
54. Human cytotoxic lymphocytes. IV. Frequency and clonal specificity of CD8+CD16-(Leu2+Leu11-) and CD16+CD3-(Leu11+Leu4-) cytotoxic lymphocyte precursors activated by alloantigen or K562 stimulator cells.
Kabelitz D
Cell Immunol; 1989 Jul; 121(2):298-305. PubMed ID: 2525425
[TBL] [Abstract][Full Text] [Related]
55. Differential expression of the interleukin 2 receptor beta (p75) chain on human peripheral blood natural killer subsets.
Nishikawa K; Saito S; Morii T; Kato Y; Narita N; Ichijo M; Ohashi Y; Takeshita T; Sugamura K
Int Immunol; 1990; 2(6):481-6. PubMed ID: 1707657
[TBL] [Abstract][Full Text] [Related]
56. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
[TBL] [Abstract][Full Text] [Related]
57. The presence and cytotoxicity of CD16+ CD2- subset from PBL and NK cells in long-term IL-2 cultures enhanced by Prothymosin-alpha.
Cordero OJ; Sarandeses C; López-Rodríguez JL; Nogueira M
Immunopharmacology; 1995 Apr; 29(3):215-23. PubMed ID: 7542644
[TBL] [Abstract][Full Text] [Related]
58. Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo.
Nagler A; Lanier LL; Phillips JH
J Exp Med; 1990 May; 171(5):1527-33. PubMed ID: 2139697
[TBL] [Abstract][Full Text] [Related]
59. Basic fibroblast growth factor and interleukins 4 and 6 stimulate the release of IFN-gamma by individual NK cells.
Lewis CE; Ramshaw AL; Lorenzen J; McGee JO
Cell Immunol; 1991 Jan; 132(1):158-67. PubMed ID: 1829652
[TBL] [Abstract][Full Text] [Related]
60. Two different maturational stages of natural killer lymphocytes in human newborn infants.
Sancho L; de la Hera A; Casas J; Vaquer S; Martínez C; Alvarez-Mon M
J Pediatr; 1991 Sep; 119(3):446-54. PubMed ID: 1715396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
